<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> is a neurogenetic disorder characterized by the loss or reduction of the ubiquitin-protein ligase E3A enzyme </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> results from a deletion or mutation of the maternally inherited 15q11.2-13.1 region, paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> of chromosome 15, or an imprinting error </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">Epilepsy</z:e> is common and may present with multiple <z:hpo ids='HP_0001250'>seizure</z:hpo> types, including <z:mp ids='MP_0000948'>nonconvulsive</z:mp> <z:hpo ids='HP_0002133'>status epilepticus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001250'>Seizures</z:hpo> are often intractable and typically require broad-spectrum <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> medications </plain></SENT>
<SENT sid="4" pm="."><plain>Dietary therapy has also proved successful in <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Electroencephalographic patterns include notched δ and rhythmic θ activity and epileptiform discharges </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0851578,C0852564" disease_type="Disease or Syndrome;Mental or Behavioral Dysfunction" abbrv="">Sleep disorders</z:e> are also common, often characterized by abnormal sleep-wake cycles </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0100022'>Movement disorders</z:hpo> are nearly universal in <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, most frequently presenting with <z:hpo ids='HP_0001251'>ataxia</z:hpo> and <z:hpo ids='HP_0001337'>tremor</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Neurocognitive impairment is always present to varying degrees, and expressive speech is typically severely affected </plain></SENT>
<SENT sid="9" pm="."><plain>Individuals with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> often manifest psychiatric comorbidities including <z:hpo ids='HP_0000752'>hyperactivity</z:hpo>, <z:hpo ids='HP_0000739'>anxiety</z:hpo>, and challenging behaviors such as <z:hpo ids='HP_0000718'>aggression</z:hpo> and self-injury </plain></SENT>
<SENT sid="10" pm="."><plain>We focus on a comprehensive whole-child approach to the diagnosis and long-term clinical care of individuals with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> </plain></SENT>
</text></document>